S

Stuart Therapeutics

5 employees

Stuart Therapeutics is a biotechnology company that offers PolyCol, a therapeutic platform for ophthalmic indications.

Basic info

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

S

Stuart Therapeutics raised $11M on March 19, 2021

Investors: InFocus Capital Partners and Wisconsin Alumni Research Foundation

FAQ